The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

Her death comes just weeks after she publicly revealed in The New Yorker that she had been diagnosed with acute myeloid ...

A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.

A groundbreaking study shows that breast cancer screening works better when it’s personalized. Instead of annual mammograms ...

A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...

Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...

On August 8, 2025, the FDA granted accelerated approval to zongertinib for adult patients with unresectable or metastatic ...

A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia. The findings offer insight into why some people are ...

At 47, Todd Leach learned he carries a genetic mutation that significantly raised his risk for a rare stomach cancer. He had ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks. Diet, obesity, and lack of early screening are playing a major role in ...